Edition:
United States

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

63.21USD
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
$63.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
496,621
52-wk High
$99.45
52-wk Low
$33.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 16.81 -1.240
Jun '17 14.62 -3.882
Mar '17 7.05 -1.328
FY 2016 Dec '16 0.08 -1.831
Sep '16 0.00 -1.705
Jun '16 0.00 -3.369
Mar '16 0.00 -2.174
FY 2015 Dec '15 0.00 -3.117
Sep '15 0.00 -2.623
Jun '15 0.00 -2.098
Mar '15 0.00 -1.857
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 11 21.29 25.43 18.80 13.89
Quarter Ending Mar-18 5 27.52 38.60 22.50 22.70
Year Ending Dec-17 13 58.78 63.90 55.27 33.76
Year Ending Dec-18 14 221.27 279.59 168.20 146.80
Earnings (per share)
Quarter Ending Dec-17 12 -1.29 -1.11 -1.42 -1.10
Quarter Ending Mar-18 6 -1.23 -0.99 -1.40 -0.95
Year Ending Dec-17 11 -7.63 -7.46 -7.76 -4.97
Year Ending Dec-18 14 -3.28 -2.08 -4.90 -1.28
LT Growth Rate (%) 1 -71.10 -71.10 -71.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 197.02 34.53
P/E High - Last 5 Yrs. -- 293.55 45.15
P/E Low - Last 5 Yrs. -- 96.34 24.17
Beta 1.55 0.86 0.89
Price to Sales (TTM) 80.37 90.86 5.22
Price to Book (MRQ) 10.35 20.00 5.51
Price to Tangible Book (MRQ) 14.41 23.35 6.98
Price to Cash Flow (TTM) -- 101.29 23.49
% Owned Institutions -- 6.31 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.10 5.30
Payout Ratio(TTM) -- 112.04 45.45

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.34 6.95
Sales (TTM) vs TTM 1 Yr. Ago -- 29.03 5.19
Sales - 5 Yr. Growth Rate -- 33.61 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.25 -141.83 4.91
EPS (TTM) vs TTM 1 Yr. Ago 20.10 -- --
EPS - 5 Yr. Growth Rate -- 43.74 11.02
Capital Spending - 5 Yr. Growth Rate 11.42 41.54 15.09

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.16 1.92 2.53
Current Ratio (MRQ) 3.19 5.60 3.53
LT Debt to Equity (MRQ) 94.28 14.40 12.25
Total Debt to Equity (MRQ) 94.28 16.77 18.21
Interest Coverage (TTM) -38.12 -145.68 43.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 81.87 43.49 54.77
Gross Margin - 5 Yr. Avg. -- 54.91 52.26
EBITD Margin (TTM) -619.55 -- --
EBITD - 5 Yr. Avg -6,444.45 -214.25 15.69
Operating Margin (TTM) -930.15 -542.82 8.05
Operating Margin - 5 Yr. Avg. -7,775.39 -229.97 11.32
Pre-Tax Margin (TTM) -950.50 -510.97 8.85
Pre-Tax Margin - 5 Yr. Avg. -7,876.53 -229.86 11.74
Net Profit Margin (TTM) -947.47 -507.97 5.09
Net Profit Margin - 5 Yr. Avg. -7,447.60 -232.83 8.01
Effective Tax Rate (TTM) -- 15.56 24.22
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.08

Efficiency

  Company industry sector
Revenue/Employee (TTM) 138,666 22,630,773 862,067,509
Net Income/Employee (TTM) -1,313,820 -1,264,069 100,498,038
Receivable Turnover (TTM) 2.71 33.44 6.11
Inventory Turnover (TTM) -- 2.69 3.51
Asset Turnover (TTM) 0.06 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -60.67 -7.85 11.35
Return on Assets - 5 Yr. Avg. -40.17 -0.11 12.39
Return on Investment (TTM) -78.93 -10.12 14.52
Return on Investment - 5 Yr. Avg. -43.69 3.11 16.22
Return on Equity (TTM) -205.06 -37.71 16.01
Return on Equity - 5 Yr. Avg. -76.86 5.83 17.36
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 7.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clovis Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -18.44 -18.55 16 58
13 Week -12.16 -17.38 30 38
26 Week 21.00 11.75 78 63
52 Week 74.13 47.68 82 42
YTD 42.30 23.54 74 43
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 342
Total Shares Held: 52,996,017
3 Mo. Net Change: 1,607,451
# New Positions: 53
# Closed Positions: 57
# Increased Positions: 198
# Reduced Positions: 134
# Net Buyers: 64
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.